WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JANUARY 10, 2013: The Seventh International Pharmaceutical Compliance Congress, www.InternationalPharmaCongress.com, will take place on May 21 - 23, 2013 at the Melia Castilla Hotel in Madrid, Spain. Registrants may attend the event in person or online (live webcast and archived for 6 months).

CONGRESSES AND REALITIES: CROSS-BORDER CONFLUENCE, TERRITORIAL ISSUES VS. GLOBAL ACTIVITIES, MIXING IFPMA/EFPIA CODES WITH CONGRESS AND SOCIETY RULES Marie-Claire Pickaert Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium Jeff Rosenbaum, MBA Vice President, Chief Compliance Officer, Vertex Pharmaceuticals, Former Executive Director, Global Head of Ethics & Compliance Novartis Oncology, Boston, MA Debra C. Forster, Esq. Global Compliance Director, Novartis Pharma AG, Former Executive Director, Marketing and Sales Compliance Boehringer Ingelheim, Basel, Switzerland Ann Beasley Bacon Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Basel, Switzerland (Moderator)

GABOR DANIELFY MEMORIAL KEYNOTE ADDRESS Elvira Sanz President, Pfizer Spain, President, Farmaindustria, Madrid, Spain ETHICS KEYNOTE ADDRESS Marc Le Menestrel, PhD Visiting Professor of Ethics, INSEAD, Associate Professor, University Pompeu Fabra (Barcelona), Barcelona, Spain KEYNOTE SPEAKERS Reinhard Angelmar, PhD Salmon and Rameau Fellow of Healthcare, Management Professor of Marketing, INSEAD, Appointments, Sloan School (MIT), Stockholm School of Economics, ESSEC Business School, and Universite Paris Dauphine, Fontainebleau, France Jose F. Zamarriego Izquierdo Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain Tamara Music Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland Marie-Claire Pickaert Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium Heather Simmonds Director and Chair, Code of Practice Panel, Prescription Medicines Code of Practice Authority, London, UK Andy Powrie-Smith Director for Trust and Reputation, Association of the British Pharmaceutical Industry (ABPI), London, UK A SPECIAL INVITATION-ONLY SPANISH COMPLIANCE ROUNDTABLE On Tuesday, May 21, 2013 immediately prior to the Congress Sponsored by FARMAINDUSTRIA FEATURING Arancha Burgos Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain Santiago Páramo Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain Jose F. Zamarriego Izquierdo Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain (Moderator) Olga Sanz Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain Julián Zabala Head of Communications, FARMAINDUSTRIA, Madrid, Spain Click here to request invitation to attend. SPECIAL SPANISH STAKEHOLDERS ROUNDTABLE Dr. José Manuel Bajo Arenas President, Spanish Federation of Scientific Medical Associations, Científico Médicas Españolas (FACME), Madrid, Spain Dra. Begoña Barragán President, Spanish Group of Cancer Patients, Madrid, Spain Dr. Antonio Cachá Deputy Director General of Pharmacy, Comunidad de Madrid (CAM), Madrid, Spain Dra. Neus Rams I Pla Deputy Director General of Pharmacy and Sanitary Products, Generalitat de Catalunya, Madrid, Spain FEATURED FACULTY Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France Vivian Lima-Barnett Latin America Ethics and Compliance Director, Abbott Laboratories, Abbott Park, IL, USA Andy Bender, MS, MBA President, Polaris, New York, NY, USA William E. Buzzeo, MS Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA Philippe Cloarec European Ethics and Compliance Associate - CCEP-I, Eli Lilly and Company, Geneva, Switzerland Peter Dieners, Esq. Partner, Clifford Chance, Düsseldorf, Germany Sue Egan Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK Gary F. Giampetruzzi, Esq. Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA Jonathon Kellerman Principal, Pharmaceutical and Life, Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Daniel A. Kracov, Esq. Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC, USA Paul J. Melling, Esq. Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia Marc L. Miller Partner, KPMG LLP, New York, NY, USA Lewis Morris, Esq. Senior Counsel, Adelman, Sheff and Smith LLC, Former Chief Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Annapolis, MD, USA Andrew Parks Director, KPMG, McLean, VA, USA Lori Queisser Principal, Advisory Services, KPMG LLP, Former Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Former Member, PCF Executive Committee, Indianapolis, IN, USA Brian Riewerts Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD, USA Guillaume Roussel Vice President, Compliance Solutions EMEA, Cegedim Relationship Management, Paris, France Vivian Robinson, Esq. Partner, McGuireWoods; Former General Counsel of the UK Serious Fraud Office; Former Head, QEB Hollis Whiteman Chambers; Recorder of the Crown Court and Treasurer of Inner Temple, London, UK Paul B. Woods, BPharm, MA, MRPharmS Independent Consultant; Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK Mariusz Witalis Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE Ann Beasley Bacon Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland (Co chair) Dominique Laymand, Esq. Vice President Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France (Co chair) Michael J. Morgan Ethics and Compliance Officer, Australia, Canada and Europe, Eli Lilly and Company, Windlesham, Surrey, United Kingdom (Co chair) Roeland Van Aelst Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium (Co chair) Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France Ronny Arijs Vice President Global Sustainability & Chief Compliance Officer, Grunenthal, Former Senior Compliance Manager GE Healthcare, Brussels, Belgium Wayne Baker Senior Vice President & Chief Sales Officer, Advanced Health Media LLC, New Providence, NJ, USA Bulent Becan Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey Andy Bender, MS, MBA President, Polaris, New York, NY, USA John T. Bentivoglio, Esq. Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC, USA Hugh C. Bigwood Ethics and Compliance Officer, International Operations, Abbott Laboratories, Horsham, West Sussex, United Kingdom Antonio Cavallaro Compliance & Internal Auditing Senior Manager, Takeda Italia Farmaceutici, Rome, Italy Peter Dieners, Esq. Partner, Clifford Chance, Dusseldorf, Germany Pierre E. Dupourque Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc., Mannheim, Germany Sue Egan Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK Annette Schutt Fiig Director, Risk Office, Novo Nordisk, Copenhagen, Denmark Gerard Geneen Vice President, Compliance Officer, Pharma Europe, GlaxoSmithKline, Brentford, Middlesex, United Kingdom Jose F. Zamarriego Izquierdo Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain Jonathon Kellerman Principal, Pharmaceutical and Life Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Tomasz Kruk Director Global Ethics & Compliance, Actavis, Zug, Switzerland Paul J. Melling, Esq. Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia Marc L. Miller Partner, KPMG LLP, New York, NY, USA Maxine Nogard Senior Director, Global Corporate Compliance, Biogen Idec Inc., Weston, MA, USA John Patrick Oroho, Esq. Executive Vice President and Chief Strategy Officer, Porzio Pharmaceutical Services, LLC; Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA Guillaume Roussel Vice President, Compliance Solutions EMEA, Cegedim, Paris, France Joseph B. Tompkins, Jr. Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division of the United States Department of Justice, Washington, DC, USA L. Stephan Vincze, JD, LL M, MBA National Managing Director, Life Sciences/Forensic and Dispute Services, Deloitte Financial Advisory Services, LLP, Boston, MA, USA Paul B. Woods, BPharm, MA, MRPharmS Independent Consultant, Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK Elisabethann Wright, Esq. Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium SAVE THE DATE FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND A Hybrid Conference and Internet Event February 19 - 21, 2013 The Ritz-Carlton Washington, DC www.DisclosureSummit.com SEVENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by International Society of Healthcare Compliance Professionals Cosponsored by Pharmaceutical Compliance Forum May 21 - 23, 2013 Meliá Castilla Hotel Madrid, Spain www.InternationalPharmaCongress.com THIRD ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by Asia Pacific Healthcare Industry Compliance Team Cosponsored by Pharmaceutical Compliance Forum September 10 - 12, 2013 Kuala Lumpur, Malaysia www.AsianPharmaCongress.com FOURTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by Pharmaceutical Compliance Forum October 28 - 30, 2013 Hyatt Regency on Capitol Hill Washington, DC www.PharmaCongress.com